Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-27

FDA Approved: IZERVAY — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for IZERVAY (avacincaptad pegol) from Astellas Pharma US, expanding its label for geographic atrophy associated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IZERVAY (avacincaptad pegol)

Snippet

SUPPL AP for IZERVAY (AVACINCAPTAD PEGOL)